Back
Foghorn Therapeutics Quote, Financials, Valuation and Earnings
Sell
45
FHTX
Foghorn Therapeutics
Last Price:
5.53
Seasonality Move:
42.54%
7 Day Trial
ALL ACCESS PASS
$
7
Foghorn Therapeutics Price Quote
$5.53
+0.02 (+-4.82%)
(Updated: May 18, 2024 at 5:43 AM ET)
Foghorn Therapeutics Key Stats
Sell
45
Foghorn Therapeutics (FHTX)
is a Sell
Day range:
$5.47 - $6.02
52-week range:
$2.70 - $9.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.85
P/B ratio:
0%
Volume:
60.7K
Avg. volume:
73.9K
1-year change:
-15.88%
Market cap:
$234.6M
Revenue:
$34.2M
EPS:
$-2.2
How Much Does Foghorn Therapeutics Make?
-
How Much Are Foghorn Therapeutics's Sales Annually?
FHTX Revenues are $34.2M -
How Much Profit Does Foghorn Therapeutics's Make A Year?
FHTX net income is -$98.4M
Is Foghorn Therapeutics Growing As A Company?
-
What Is Foghorn Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.05% -
What Is Foghorn Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Foghorn Therapeutics Stock Price Performance
-
Did Foghorn Therapeutics Stock Go Up Last Month?
Foghorn Therapeutics share price went down by -4.67% last month -
Did FHTX's Share Price Rise Over The Last Year?
FHTX share price fell by -15.88% over the past 1 year
What Is Foghorn Therapeutics 52-Week High & Low?
-
What Is Foghorn Therapeutics’s 52-Week High Share Price?
Foghorn Therapeutics has traded as high as $9.97 over the past 52 weeks -
What Is Foghorn Therapeutics’s 52-Week Low Share Price?
Foghorn Therapeutics has traded as low as $2.70 over the past 52 weeks
Foghorn Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Foghorn Therapeutics?
-
How Much Debt Does Foghorn Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Foghorn Therapeutics Have?
Cash and short term investments quarterly total is $206.7M -
What Is Foghorn Therapeutics’s Book Value Per Share?
Book value per share is -2.29
Is Foghorn Therapeutics Cash Flow Positive?
-
What Is FHTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$116.3M -
What Is Foghorn Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $2.8M -
What Is Foghorn Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $142M
Foghorn Therapeutics Return On Invested Capital
Data Unavailable
Foghorn Therapeutics Earnings Date & Stock Price
-
What Is Foghorn Therapeutics's Stock Price Today?
A single share of FHTX can be purchased today for 5.51 -
What Is Foghorn Therapeutics’s Stock Symbol?
Foghorn Therapeutics trades on the nasdaq under the ticker symbol: FHTX -
When Is Foghorn Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Foghorn Therapeutics is scheduled on August 2, 2024 -
When Is FHTX's next ex-dividend date?
Foghorn Therapeutics's next ex-dividend date is May 19, 2024 -
How To Buy Foghorn Therapeutics Stock?
You can buy Foghorn Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Foghorn Therapeutics Competitors
-
Who Are Foghorn Therapeutics's Competitors?
Below is a list of companies who compete with Foghorn Therapeutics or are related in some way:
Foghorn Therapeutics Dividend Yield
Data Unavailable
Foghorn Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -4.88% | -31.31% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 11.67 |
| Upside from Last Price: | 111.74% |